Adaptive radiosurgery based on two simultaneous dose prescriptions in the management of large renal cell carcinoma brain metastases in critical areas: Towards customization.
Conclusion: Despite poor prognosis and precluding clinical factors (failing systemic treatment, eloquent location, and radioresistant histology), RRR provided optimal tumor ablation and salvage of neurofunction with limited toxicity throughout follow-up.
PMID: 32123609 [PubMed]
Source: Surgical Neurology International - Category: Neurosurgery Tags: Surg Neurol Int Source Type: research
More News: Brain | Brain Cancers | Cancer & Oncology | Carcinoma | Kidney Cancer | MRI Scan | Neurology | Neurosurgery | Renal Cell Carcinoma | Toxicology